readthroughSign in
CompanyZYMENasdaqMiddletown, DE

Zymeworks Inc.

Zymeworks develops commercial and clinical-stage biotherapeutics including the bispecific antibody zanidatamab and multispecific antibodies using its Azymetric platform.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 9Latest story